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This guided final thesis studied the Endoglin and Spirulina platensis in the process of 
atherosclerosis both in vivo and in vitro and their effects on specific pro- or anti-atherogenic 
markers, particularly with regard to the vascular endothelium. 
Endoglin (CD 105, TGF-β receptor III ENG) is a homodimeric membrane 
glycoprotein, which plays a regulatory role in TGFβ signaling. The relation between endoglin 
and endothelial NO synthase (eNOS) is essential for our study. Endoglin increases eNOS 
expression and promotes the production of NO, which affects the function of vascular 
endothelium. Changes in the expression of eNOS and endoglin could thus be associated with 
the development of endothelial dysfunction, a key step in atherogenesis. 
In our studies, we investigated the effects of cholesterol (1% cholesterol diet) and 
statins (atorvastatin) with respect to endoglin expression and soluble endoglin levels in a 
mouse model of atherosclerosis. Hypercholesterolemia increased levels of soluble endoglin in 
blood and reduced its expression in the aorta, together with some protective markers of 
atherosclerosis, such as p-Smad2 and VEGF. Other results showed that statins increased 
endoglin levels as well as other protective markers of atherosclerosis and also reduced the size 
of atherosclerotic lesions beyond the hypolipidemic effect. In addition, atorvastatin treatment 
simultaneously reduced the levels of soluble endoglin, suggesting that monitoring of endoglin 
levels might represents a promising marker of the progression or treatment of atherosclerosis. 
Spirulina platensis is a blue-green alga belonging to the group of cyanobacteria. It is a 
human and animal food supplement. It contains protein complexes with linear tetrapyroles 
called phycobiliprotein composed of protein part (fycocyanins) and linear tetrapyroles 
(fycocyanobilins). Fycocyanobilin (PCB) is biliverdin derivate, which is converted to 
fycocyanorubin by the enzyme called biliverdin reductase. This substance is nearly identical 
in structure as bilirubin, which is known to have protective effects on atherogenesis. 
Based on this information we studied the effect of Spirulina and PCB on the expression and 
activity of heme oxygenase-1 (HMOX1, HO-1), which is the key enzyme in the catabolism of 
heme with significant atheroprotective properties in vivo and in vitro. The in vitro study on 
endothelial cells showed a strong activating effect on the expression of HO-1 and the activity 
of this enzyme not only by Spirulina but also by PCB. We also observed increased levels of 
endothelial NO synthase and reduction of the expression of cell adhesion molecules VCAM-1 
after administration of Spirulina in endothelial cells, which provide evidence of the potential 
atheroprotective effect. 
These in vitro data were confirmed in in vivo study in ApoE-deficient mice fed by 
cholesterol. Administration of Spirulina platensis resulted in a significant increase of 
atheroprotective HO-1 and eNOS in atherosclerotic lesions in the aorta. It seems that the 
influence of Spirulina to induce HO-1 is universal, because we were able to clearly 
demonstrate the upregulation of HO-1 transcription and function (enzyme activity) levels in 
the spleen HMOX-luc Tg mice. 
For these reasons, the activation of HO-1 (together with the direct effects of PCB) 
represents an interesting mechanism to administration of Spirulina platensis, which may 
contribute to the positive effects on atherosclerosis. 
In conclusion, we showed that tissue and soluble endoglin might play role in 
atherogenic process and soluble endoglin might be promising biomarker of atherogenesis 
and/or atherosclerosis. In addition, we demonstrated that Spirulina platensis is able to induce 
expression and activity of atheroprotective enzyme heme oxygenase-1, which makes it 
together with previously shown antioxidant and hypolipidemic effects an interesting food 
supplement for cardiovascular prevention. 
